Skip to main content
. 2018 Apr 7;41(8):753–765. doi: 10.1007/s40264-018-0659-x

Table 2.

Antimalarial drugs and the respective ADRs reported

Drug name No. of patients No. of patients reporting at least one suspected ADR (%)
ALU 761 174 (22.9)
ASAQ 11 2 (18.2)
DHAPQ 3 0 (0)
Others 7 0 (0)
Total 782 176 (22.5)

ADRs adverse drug reactions, ALU artemether/lumefantrine, ASAQ artesunate/amodiaquine, DHAPQ dihydroartemisinin/piperaquine